Literature DB >> 107820

The association of neurofibromatosis and hyperparathyroidism.

S Chakrabarti, A Murugesan, E J Arida.   

Abstract

Two patients with coexisting neurofibromatosis and hyperparathyroidism are described, bringing the total number of such cases in the world literature to seven. Other more classic examples of the association of tumorous conditions of neuroectodermal and entodermal origin are discussed to support the suggestion that the association of these two diseases may be another variant of multiple endocrine neoplasia type 2 (MEN2b). It may be clinically profitable to investigate all patients with either disease in order to uncover their coexistence.

Entities:  

Mesh:

Year:  1979        PMID: 107820     DOI: 10.1016/0002-9610(79)90079-5

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  5 in total

1.  Hypercalcemic hyperparathyroidism and hypophosphatemic osteomalacia complicating neurofibromatosis.

Authors:  R S Weinstein; R L Harris
Journal:  Calcif Tissue Int       Date:  1990-06       Impact factor: 4.333

2.  Water-clear cell parathyroid adenoma causing primary hyperparathyroidism in a patient with neurofibromatosis type 1: report of a case.

Authors:  Hitomi Kodama; Masatoshi Iihara; Takahiro Okamoto; Takao Obara
Journal:  Surg Today       Date:  2007-09-26       Impact factor: 2.549

3.  Subepidermal Calcified Nodule in a Child With Neurofibromatosis Type 1.

Authors:  Buket Bagci; Cansu Karakas; Murat Gokden
Journal:  Cureus       Date:  2022-03-17

4.  Concurrent primary hyperparathyroidism and pheochromocytoma in a Chinese lady with neurofibromatosis type 1.

Authors:  Cheuk-Lik Wong; Chun-Kit Fok; Vicki Ho-Kee Tam
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2018-03-28

5.  Parathyroid adenoma and bilateral pheochromocytoma in a patient with neurofibromatosis.

Authors:  Basmah Al-Wahhabi
Journal:  Ann Saudi Med       Date:  2005 May-Jun       Impact factor: 1.526

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.